Microtracer‐Based Assessment of the Mass Balance, Pharmacokinetics, and Excretion of [14C]Berzosertib, an Intravenous ATR Inhibitor, in Patients With Advanced Solid Tumors: A Phase 1 Study.
Saved in:
| Title: | Microtracer‐Based Assessment of the Mass Balance, Pharmacokinetics, and Excretion of [14C]Berzosertib, an Intravenous ATR Inhibitor, in Patients With Advanced Solid Tumors: A Phase 1 Study. |
|---|---|
| Authors: | Bolleddula, Jayaprakasam1 (AUTHOR), Scheible, Holger2 (AUTHOR), Huber, Florian2 (AUTHOR), Seithel‐Keuth, Annick2 (AUTHOR), Schieferstein, Hanno2 (AUTHOR), Vagge, Deepthi S.3 (AUTHOR), Mammasse, Nadra4 (AUTHOR), Jaks, Eva2 (AUTHOR), Ferrer, Jordi2 (AUTHOR), Moulin, Camilo2 (AUTHOR), Dong, Jennifer1 (AUTHOR) jennifer.dong@emdserono.com, Venkatakrishnan, Karthik1 (AUTHOR), Papai, Zsuzsanna5 (AUTHOR) |
| Source: | Clinical Pharmacology in Drug Development. Sep2025, Vol. 14 Issue 9, p700-709. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2160763X |
|---|---|
| DOI: | 10.1002/cpdd.1554 |
